]>
IRCT20221108056444N1 IRCT 2023-02-12 Oroumia University of Medical Sciences Comparison of the effectiveness of Cinnarizine V/S Topiramate in migraine prophylaxis of children Comparison of the effectiveness of Cinnarizine V/S Topiramate in migraine prophylaxis of children referred to pediatric neurology clinic 2022-09-23 anticipated 60 Complete https://irct.ir/trial/66774 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Blocked randomization method will be used for randomization. In this way, blocks of size 6 (AAABBB) will be determined first and all possible states of this combination will be listed. For each one, a specific code will be given and in Further, according to the size of the blocks (6) and the sample size (60), the number of 10 blocks will be selected by a simple random method. The entire randomization process will be done using the RANDOM ALLOCATION software. 3 Migraine. Intervention 1: The intervention in the present study will be the administration of two drugs, cinnarizine and topiramate. The drug cinnarizine in the form of tablets with a dose of 25 mg will be administered daily in the morning for 12 weeks. Intervention 2: The drug topiramate in the form of tablets with a dose of 25 mg in the morning to It will be prescribed for 12 weeks. Yes - There is a plan to make this available What will be shared: All data may be published When: Since 2023 To whom: Access for all Conditions: Doctors and researchers Where to obtain: Researcher , 09149491518 How to obtain: Contact with the researcher, the reason for the need to receive data Comments:
public Aisan Abazarlou
Motahari Hospital, Kashani Street
Urmia Iran (Islamic Republic of) 57146154637 +98 44 3223 7077 draisanabazarlou@yahoo.com Oroumia University of Medical Sciences scientific Aisan Abazarlou
No.30 , Adili Alley , Pasdaran Alley , Valiasr Blv , khoy City , West azerbayjan
Urmia Iran (Islamic Republic of) 5815614879 +98 44 3625 8305 draisanabazarlou@yahoo.com Oroumia University of Medical Sciences Iran (Islamic Republic of) Children with migraine The need for prophylactic treatment Age 6-15 years 6 years 15 years Both Patients with advanced migraine who need drugs other than painkillers Previous history of receiving prophylactic treatment Abnormal brain and nerve imaging and special conditions such as seizures, epilepsy or the presence of contraindications for the use of cinnarizine and topiramate G43 Migraine Treatment - Drugs Treatment - Drugs The intervention in the present study will be the administration of two drugs, cinnarizine and topiramate. The drug cinnarizine in the form of tablets with a dose of 25 mg will be administered daily in the morning for 12 weeks. The drug topiramate in the form of tablets with a dose of 25 mg in the morning to It will be prescribed for 12 weeks. Headache. Timepoint: At the beginning of the study, 1, 3, 6, 9, and 12 weeks after the start of treatment. Method of measurement: Migraine Questionnaire. Oroumia University of Medical Sciences Approved 2022-10-22 Ethics Committee of Urmia University of Medical Sciences Serah Kashani, Motahari Hospital Urmia West Azarbaijan Iran (Islamic Republic of)